logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2018—Palbociclib dose decrease dampens hematologic AEs

Reduced hematologic adverse events during treatment of HR+/HER2‒ advanced breast cancer.